As part of its rulemaking process, the U.S. Food and Drug Administration (FDA) is required to conduct an economic impact analysis that assesses the costs and benefits of proposed regulations and to select the option that maximizes the net economic benefit. There are numerous challenges inherent in conducting this type of analysis, from fully.assessing the various costs and benefits of proposed rules to quantifying these costs and benefits, often with incomplete data and evidence. The comments provided to FDA on the economic impact analysis contained in its proposed rule on required warnings for cigarette packages and advertisements highlighted these challenges. The overarching aim of this project is to produce new evidence that will inform and refine the FDA's economic impact assessments of future proposed rules. This will be done through a combination of behavioral economics experiments with original data collection, acquisition of existing archival, survey, and commercial databases, and merged data analyses that address the issues discussed above, as well as others that emerge in coming years. To accomplish this, a variety of . activities vvili be done to address three specific aims that together address most of the FDA's research priorities around understanding the role of economics and policies on tobacco use and perceptions.
Aim 1 : assess the impact of FDA regulatory actions and other tobacco control policies on tobacco use and related outcomes, including the impact on trajectories of tobacco use among young people and adults, the differential impact of these actions on disparate populations, and the differential impact on the use of traditional and emerging tobacco products.
Aim 2 : Assess the impact of FDA regulatory actions and other tobacco control policies on the consumer surplus obtained by tobacco users through a behavioral economics experiment that will quantify the extent of present bias, projection bias, and time inconsistencies in decisions about tobacco use and the implications of these biases for assessing changes in consumer surplus.
Aim 3 : Extend the range of costs and benefits including in assessing the economic impact of FDA regulatory actions to include a broader set of health and economic benefits than that included in previous FDA assessments.

Public Health Relevance

There are numerous challenges inherent in conducting the type of economic impact analysis FDA is required to conduct as part of its rulemaking process. This project will produce new evidence that addresses these challenges and better informs the FDA's economic impact assessments of future proposed rules concerning tobacco products.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA036128-02
Application #
8737855
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Georgia State University
Department
Type
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30302
Majeed, Ban A; Nyman, Amy; Sterling, Kymberle L et al. (2018) Little cigars and cigarillos: Affect and perceived relative harm among U.S. adults, 2015. Addict Behav 85:107-112
Pechacek, Terry Frank; Nayak, Pratibha; Slovic, Paul et al. (2018) Reassessing the importance of 'lost pleasure' associated with smoking cessation: implications for social welfare and policy. Tob Control 27:e143-e151
Spears, Claire Adams; Jones, Dina M; Weaver, Scott R et al. (2018) Motives and perceptions regarding electronic nicotine delivery systems (ENDS) use among adults with mental health conditions. Addict Behav 80:102-109
Weaver, Scott R; Kim, Hyoshin; Glasser, Allison M et al. (2018) Establishing consensus on survey measures for electronic nicotine and non-nicotine delivery system use: Current challenges and considerations for researchers. Addict Behav 79:203-212
Yang, Bo; Owusu, Daniel; Popova, Lucy (2018) Testing messages about comparative risk of electronic cigarettes and combusted cigarettes. Tob Control :
Gibson, Laura A; Creamer, MeLisa R; Breland, Alison B et al. (2018) Measuring perceptions related to e-cigarettes: Important principles and next steps to enhance study validity. Addict Behav 79:219-225
Shang, Ce; Weaver, Scott R; Zahra, Nahleen et al. (2018) The Association between Potential Exposure to Magazine Ads with Voluntary Health Warnings and the Perceived Harmfulness of Electronic Nicotine Delivery Systems (ENDS). Int J Environ Res Public Health 15:
Dutra, Lauren McCarl; Nonnemaker, James; Taylor, Nathaniel et al. (2018) Deception and Shopping Behavior Among Current Cigarette Smokers: A Web-Based, Randomized Virtual Shopping Experiment. JMIR Res Protoc 7:e10468
Barrington-Trimis, Jessica L; Gibson, Laura A; Halpern-Felsher, Bonnie et al. (2018) Type of E-Cigarette Device Used Among Adolescents and Young Adults: Findings From a Pooled Analysis of Eight Studies of 2166 Vapers. Nicotine Tob Res 20:271-274
Popova, Lucy; Lempert, Lauren Kass; Glantz, Stanton A (2018) Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims. Tob Control 27:s87-s95

Showing the most recent 10 out of 50 publications